Genus (OTCMKTS:GENSF) Trading Down 12.4% – Here’s What Happened

Genus plc (OTCMKTS:GENSF) traded down 12.4% on Wednesday . The company traded as low as $31.50 and last traded at $31.50. 600 shares were traded during mid-day trading, an increase of 63% from the average session volume of 367 shares. The stock had previously closed at $35.9650.

Wall Street Analysts Forecast Growth

Separately, BNP Paribas Exane began coverage on shares of Genus in a report on Monday, April 27th. They issued a “neutral” rating for the company. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Genus Price Performance

The business’s 50-day simple moving average is $35.12 and its 200 day simple moving average is $35.44.

About Genus

Genus plc, trading on the OTCMKTS under the symbol GENSF, is a global leader in innovative animal genetics and breeding solutions. The company operates through two primary business segments: ABS and PIC. ABS focuses on bovine genetics, offering dairy and beef cattle semen, advanced reproductive technologies and digital herd management tools. PIC specializes in porcine genetics, providing breeding stock, genetic evaluation services and production support aimed at optimizing growth performance, health and sustainability across the global swine industry.

With origins dating back to its establishment in 1933 as the British Dairy Cattle Breeders’ Society, Genus has expanded through strategic acquisitions and organic growth to build a leading position in animal biotechnology.